The average one-year price target for Alignment Healthcare (NasdaqGS:ALHC) has been revised to $25.42 / share. This is an increase of 11.78% from the prior estimate of $22.74 dated January 11, 2026.

Investing.com - Stifel raised its price target on Align Technology (NASDAQ:ALGN) to $210.00 from $200.00 on Thursday, while maintaining a Buy rating on the dental products company. This target aligns ...

AI safety tests found to rely on 'obvious' trigger words; with easy rephrasing, models labeled 'reasonably safe' suddenly fail, with attacks succeeding up to 98% of the time. New corporate research ...

This new target aligns closely with InvestingPro ’s Fair Value assessment, which suggests the stock is currently slightly undervalued. Align Technology reported fourth-quarter revenue of $1,048 ...

Shareholders of Align Technology, Inc. (NASDAQ:ALGN) will be pleased this week, given that the stock price is up 15% to US$188 following its latest full-year results. Align Technology reported in line ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Equity Bancshares is back in focus as the market digests a ...

Natural gas strengthened Friday, holding above $2.96 and reclaiming key levels. A bullish wedge breakout and AVWAP recovery support further upside toward $3.15–$3.19. Natural gas extended its advance ...

Since March 2025, the Trump administration has used tools from Palantir and the startup Credal AI to weed out “DEI” and “gender ideology" from child welfare programs. Neither Palantir nor HHS has ...

) has been revised to $25.42 / share. This is an increase of 11.78% from the prior estimate of $22.74 dated January 11, 2026. The price target is an average of many targets provided by analysts. The ...

In a recent educational webinar from Senior Market Strategist John Rowland, CMT, he explains how Average True Range (ATR) can be used to set profit targets that align with how a stock actually moves, ...

John Morici stated, "We expect Q1 2026 worldwide revenues to be in the range of $1.01 billion to $1.03 billion, up 3% to 5% year-over-year." Morici projected, "We expect Q1 '26 Clear Aligner volume to ...